NCT06893757Recruiting
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France - ANRS 464s FrenchTB
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
The French Tuberculosis Cohort is a prospective, national, multicenter, low-intervention study including subjects aged 18 years and older with tuberculosis disease for which inpatient treatment is initiated. The goal of this observational study is to follow-up and anti-tuberculosis treatment will be provided according to current French recommendations. Participants will provide sociodemographic, clinical, biological, radiological and bacteriological data at various protocol visits at 2 days, 1 and 2 weeks, 2 months, at the end of treatment, 12 and 24 months. Consenting participants will have samples collected at scheduled visits for the establishment of a biobank. This will include blood, urine, breath and hair samples. The positive mycobacterial strains will constitute a specimen bank.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 7 Mar 2025
- Start date
- 6 May 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Diseases
- Tuberculosis
- NCT number
- NCT06893757
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 6 May 2026 to the primary completion date, Jun 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of significant cognitive impairment that, in the opinion of the site investigator or designated person, may affect the ability to give reliable informed consent (except in the specific case of meningeal tuberculosis).
Who the study is looking for
- Aged ≥18 years.
- Diagnosis of tuberculosis by microbiological or clinical means, including on the basis of a pathological examination for extrapulmonary tuberculosis leading to a Compulsory Declaration (CD) and treated for less than 8 days.
- Have signed a voluntary, informed and written consent (at the latest on the day of inclusion and before any examination carried out as part of the research), or alternatively, consent from relatives in cases of tuberculous meningitis or other serious forms of tuberculosis with impaired consciousness or confusion, until the person is able to give their consent.
Age in the registry: 18 years to - · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AP-HP Hôpital Saint Louis - Service des Maladies Infectieuses et Tropicales Coordinator of this site? Confirm its status | Paris | France | Not yet recruiting |
| Service de pneumologie et maladies infectieuses, Centre hospitalier Delafontaine Coordinator of this site? Confirm its status | Saint-Denis | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.